Clinical Trial Update: "Observational, Retrospective and Prospective, Non-interventional, Multicentre on the Use of Genomic Testing in the Management of Early Stage HR+/HER2- Breast Cancer"

View source ↗

Summary

A multicenter, non-interventional study assessing how genomic testing informs management of early-stage HR+/HER2- breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Consorzio Oncotech | Conditions: Breast Cancer | Status: NOT_YET_RECRUITING